We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Novel Method Identifies Pathogens in Bone Marrow Smears

By LabMedica International staff writers
Posted on 09 Jun 2015
The rapid identification of four pathogens and the early diagnosis of the four different diseases are of great importance; however some pathogens have a similar size and shape in the Wright‑Giemsa staining of bone marrow smears. More...


A novel method has been developed to rapidly identify the pathogens Penicillium marneffei, Histoplasma capsulatum, Mucor, and Leishmania donovani in bone marrow smears that can lead to the diseases penicilliosis marneffei, histoplasmosis, mucormycosis, and leishmaniasis, respectively.

Clinical laboratory scientists at Guangxi Medical University (Nanning, China) obtained 55 bone marrow smears (BMS) that were infected. There were 25 invaded by P. marneffei, 10 with H. capsulatum, 3 with Mucor, and 17 infected by L. donovani. The diagnosis of the four diseases was confirmed by pathogen culture. Each BMS was fixed by 95% alcohol for 10 minutes, prior to being washed, dried, stained by 1% periodic acid for 20 minutes and washed and dried once more. Each BMS was then stained by a Schiff reagent for 60 minutes, washed and dried, and subsequently stained by hematoxylin for five minutes, washed and dried. The BMSs were observed using light microscopy. Wright‑Giemsa staining was also performed, following standard protocols.

In the Wright Giemsa staining, the four pathogens were approximately the same size and mainly existed in macrophages. The multiplying P. marneffei had two nuclei, which were on both sides of the fungus, and had light cross walls in the middle. H. capsulatum had a purplish nucleus, which occupied between one third and one half of the spore. The cytoplasm was light blue. Peripheral spores were observed in the form of an empty, bright ring without color, like a capsule.

Generally Mucor were observed to have a long and lightly stained area, which could be confused with the Wright staining of dinuclear P. marneffei. L. donovani exhibited a deep staining kinetoplast near the nucleus. In the Periodic Acid Schiff (PAS) staining, the pathogens of P. marneffei and H. capsulatum were distinct and stained red.

The authors concluded that their staining method was simple and can enable the rapid diagnosis of penicilliosis marneffei, histoplasmosis, mucormycosis and visceral leishmaniasis. Furthermore, the method may have an important role in diag-nosing the four diseases in cases in which it is not possible to conduct pathogen culture and serology tests. The study was published in the May 2015 issue of the journal Experimental and Therapeutic Medicine.

Related Links:

Guangxi Medical University 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Portable POCT Blood Gas Analyzer
BD100
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.